2021 annual financial data
bioAffinity Technologies 2021 Operating margin
Direct answer
Operating margin was -168,975.65%.
Operating income was -2,206,822 USD and net income was -6,326,413 USD.
Operating cash flow was -2,048,978 USD.
Get free bioAffinity Technologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,306 USD
- Operating income
- -2,206,822 USD
- Net income
- -6,326,413 USD
- Operating cash flow
- -2,048,978 USD